Castrate-Resistant Prostate Cancer Market (By Therapy – Chemotherapy, Hormonal Therapy, Immunotherapy, Radiotherapy. By Geography – North America, Latin America, Europe, Asia Pacific, Middle East and Africa.) - Global industry analysis, size, share, growth, trends and forecast, 2021 – 2031.
Report Type : Syndicate Report
The Global Castrate-Resistant Prostate Cancer Market was valued at $9.9 Billion in 2020. Growing at a high CAGR of more than 8.93% between 2021 and 2031, it is estimated to reach $25.4 Billion by 2031. But due to the current COVID-19 pandemic, there might be a slight difference in the growth rate in the present year. increased prevalence of castrate-resistant prostate cancer increased adoption of the novel drugs and unhealthy lifestyle are the main factors that will help to accelerate the growth of this market during the forecasted period.
Global Castrate-Resistant Prostate Cancer Market Is Estimated To Witness Remarkable Growth
Source: SAI Research
The Global Castrate-Resistant Prostate Cancer Market has been segmented into therapy, and so on the basis of therapy Global Castrate-Resistant Prostate Cancer Market has been divided into Chemotherapy, Hormonal Therapy, Immunotherapy, Radiotherapy.
By Region, North America Is Holding The Major Market Share
The Global Castrate-Resistant Prostate Cancer Market has been geographically segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. In addition to this, North America Global Castrate-Resistant Prostate Cancer Market is holding the largest market share at present and is estimated to witness a high compound annual growth rate during the upcoming forecasted period. high prevalence of the diseases, presence of key players, and favorable reimbursement policies are the main factors that have led this region to dominate the market during the forecasted period. besides this Asia Pacific is also going to witness remarkable growth during the forecasted period.
Request a Sample Copy of Report
Major Players in Global Castrate-Resistant Prostate Cancer Market
Some of the major players in the Global Castrate-Resistant Prostate Cancer Market include Sanofi, Johnson & Johnson Services, Inc., Pfizer, Inc., Astellas Pharma, Inc., Bayer AG.
Scope of the Report:
|
Report Coverage |
Details |
||
|
Base Year: |
2020 |
Market Size in 2020: |
US$ 9.9 Billion |
|
Historical Data for: |
2018 to 2020 |
Forecast Period: |
2021 to 2031 |
|
Forecast Period 2021 to 2031 CAGR: |
8.93% |
2031 Value Projection: |
US$ 25.4 Billion |
|
Segments covered: |
By Therapy – Chemotherapy, Hormonal Therapy, Immunotherapy, Radiotherapy |
||
|
Geographies covered: |
North America: U.S., Canada, Mexico Europe: Germany, U.K., Spain, France, Italy, Russia, Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Africa: South Africa, North Africa, and Africa Middle East: GCC, Israel, and Rest of Middle East Latin America: Brazil, Argentina, Rest of Latin America |
||
|
Companies covered: |
Sanofi, Johnson & Johnson Services, Inc., Pfizer, Inc., Astellas Pharma, Inc., Bayer AG. |
||
The Global Castrate-Resistant Prostate Cancer Market Has Been Segmented Into:
Global Castrate-Resistant Prostate Cancer Market, By Therapy
- Chemotherapy
- Hormonal Therapy
- Immunotherapy
- Radiotherapy
Global Castrate-Resistant Prostate Cancer Market, By Country
- North America
- USA
- Canada
- Mexico
- Rest of North America
- Europe
- UK
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- India
- China
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America, Middle East & Africa
- Brazil
- South Africa
- UAE
- Rest of LAMEA
Buy Chapters or Sections
Customization options available to meet your custom research requirements :
- Request a part of this report
- Get geography specific report
- Request historical analysis
- Check out special discounted pricing
Why Choose Us
24/5 Research supportGet queries resolved by industry expert.
Custom research serviceExclusive reports and studies to meet your custom requirements.
Quality assuranceWidely acclaimed services reccomended by major organizations.
Information securityYour personal information security guaranteed.
